Holen Sie sich die Stockscreener-App
133.40
0.76%
-0.94
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$134.34
Offen:
$135.21
24-Stunden-Volumen:
566.04K
Relative Volume:
0.37
Marktkapitalisierung:
$38.06B
Einnahmen:
$6.51B
Nettoeinkommen (Verlust:
$1.29B
KGV:
34.92
EPS:
3.82
Netto-Cashflow:
$1.37B
1W Leistung:
-1.85%
1M Leistung:
-4.48%
6M Leistung:
+5.99%
1J Leistung:
-3.91%
1-Tages-Spanne:
$132.87
$135.73
1-Wochen-Bereich:
$132.87
$136.22
52-Wochen-Spanne:
$124.16
$155.35
Agilent Technologies Inc Stock (A) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
(408) 345-8886
Adresse
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Vergleichen Sie A mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
133.37 | 38.06B | 6.51B | 1.29B | 1.37B | 4.42 |
|
TMO
Thermo Fisher Scientific Inc
|
521.78 | 199.03B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
229.31 | 165.46B | 23.74B | 3.89B | 4.98B | 5.24 |
|
IQV
Iqvia Holdings Inc
|
194.97 | 35.36B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
408.07 | 33.35B | 3.84B | 866.24M | 792.60M | 10.37 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-11-17 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Bestätigt | Barclays | Equal Weight |
| 2023-05-24 | Bestätigt | BofA Securities | Buy |
| 2023-05-24 | Bestätigt | Citigroup | Neutral |
| 2023-05-24 | Bestätigt | Credit Suisse | Outperform |
| 2023-05-24 | Bestätigt | Evercore ISI | Outperform |
| 2023-05-24 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Bestätigt | Robert W. Baird | Outperform |
| 2023-05-24 | Bestätigt | SVB Securities | Outperform |
| 2023-05-24 | Bestätigt | Stifel | Hold |
| 2023-05-24 | Bestätigt | TD Cowen | Outperform |
| 2023-05-24 | Bestätigt | Wells Fargo | Overweight |
| 2023-05-11 | Eingeleitet | Barclays | Equal Weight |
| 2023-01-10 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-07-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Bestätigt | BofA Securities | Buy |
| 2022-02-23 | Bestätigt | Citigroup | Buy |
| 2022-02-23 | Bestätigt | Cowen | Outperform |
| 2022-02-23 | Bestätigt | Evercore ISI | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2021-11-23 | Bestätigt | BofA Securities | Buy |
| 2021-11-23 | Bestätigt | Cowen | Outperform |
| 2021-11-23 | Bestätigt | Stifel | Hold |
| 2021-03-18 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Hochstufung | UBS | Neutral → Buy |
| 2020-11-17 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Neutral |
| 2020-08-19 | Bestätigt | BofA Securities | Neutral |
| 2020-08-19 | Bestätigt | Citigroup | Neutral |
| 2020-08-19 | Bestätigt | Jefferies | Buy |
| 2020-08-19 | Bestätigt | Robert W. Baird | Outperform |
| 2020-08-19 | Bestätigt | SVB Leerink | Outperform |
| 2020-08-19 | Bestätigt | Stifel | Hold |
| 2020-08-19 | Bestätigt | Wells Fargo | Overweight |
| 2020-02-24 | Herabstufung | Needham | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-26 | Bestätigt | Needham | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-18 | Herabstufung | UBS | Buy → Neutral |
| 2019-07-16 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
Agilent Technologies (A) Rebounded in Q3 Following an Encouraging Earnings Release - Yahoo Finance
Agilent Technologies Inc. stock rises Tuesday, outperforms market - MarketWatch
Agilent Technologies, Inc. (NYSE:A) Short Interest Up 9.8% in December - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Shares Sold by JPMorgan Chase & Co. - MarketBeat
Agilent Technologies Inc. stock falls Monday, still outperforms market - MarketWatch
Biomarkers Market Detailed In New Research Report 2024 | Agilent - openPR
Functional Genomics Market Top Companies StudyAgilent - openPR
NGS Data Storage Market Top PlayersAgilent Technologies, Inc., BGI Group, DNAnexus, Inc, Fabric Genomics, Inc. - openPR
Jim Cramer on Agilent Technologies, Inc. (A): ‘They Told A Pretty Good Story’ - Insider Monkey
8 Stocks on Jim Cramer’s Radar - Insider Monkey
Agilent Technologies Inc. stock outperforms market despite losses on the day - MarketWatch
Ex-Dividend Reminder: Ensign Group, Agilent Technologies and Stryker - Nasdaq
Agilent Technologies Inc. stock falls Thursday, underperforms market - MarketWatch
Agilent (A) Up 1.3% Since Last Earnings Report: Can It Continue? - MSN
Agilent Technologies (NYSE:A) Raised to Buy at StockNews.com - MarketBeat
Is the Options Market Predicting a Spike in Agilent (A) Stock? - MSN
Smart Syringes Market Top PlayersAgilent Technologies, Inc., - openPR
Dudley & Shanley Inc. Takes Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies Inc. stock rises Monday, still underperforms market - MarketWatch
Tissue Diagnostic Market Detailed in New Research Report By 2031 | Biocare Medical, Agilent technologies - EIN News
Principal Financial Group Inc. Trims Stake in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Q3 EPS Forecast for Agilent Technologies Raised by Analyst - MarketBeat
Agilent Technologies Navigates AI Integration Challenges Amid Regulatory and Ethical Concerns - MSN
Agilent Technologies Inc. stock rises Friday, still underperforms market - MarketWatch
Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference - WebWire
AAgilent Technologies Inc. Latest Stock News & Market Updates - StockTitan
Q2 EPS Forecast for Agilent Technologies Reduced by Analyst - MarketBeat
Agilent Technologies Inc. (A) reports earnings - Quartz
Agilent Technologies Inc. stock rises Thursday, outperforms market - MarketWatch
Agilent Technologies to Present at J.P. Morgan Healthcare Conference 2025: Key Investor Event Ahead - StockTitan
August 2025 Options Now Available For Agilent Technologies (A) - Nasdaq
Agilent Technologies (NYSE:A) Price Target Raised to $165.00 - MarketBeat
Stifel reiterates Buy on Agilent stock, highlights 2025 growth drivers - Investing.com
Baird reiterates Outperform rating on Agilent stock, highlights strategic growth drivers - Investing.com
Agilent shares steady after Investor Day, Bernstein notes reaffirmed 2025 guidance By Investing.com - Investing.com
Gas Chromatography Market to hit USD 5.6 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
Agilent Technologies Inc. stock falls Tuesday, underperforms market - MarketWatch
Agilent's SWOT analysis: life sciences firm faces headwinds amid expansion - Investing.com
Agilent Technologies Inc. stock falls Monday, underperforms market - MarketWatch
3,604 Shares in Agilent Technologies, Inc. (NYSE:A) Purchased by Wilmington Savings Fund Society FSB - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Short Interest Update - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Franklin Resources Inc. Trims Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Bank of America Cuts Agilent Technologies (NYSE:A) Price Target to $150.00 - MarketBeat
Stifel Financial Corp Cuts Stake in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent/DSU collaboration strengthens with $250k gift at Scholarship Ball - newsbreak.com
Agilent Technologies Inc. stock falls Friday, underperforms market - MarketWatch
Agilent Technologies (A) Announces Reorganization of Operational Structure - GuruFocus.com
Metagenomics Market Report by Product, Technology, - GlobeNewswire
Metagenomics Market Report by Product, Technology, Application, and Region (2024-2032) Featuring Profiles of Agilent Technologies, Enterome, Eurofins Scientific, Roche, Illumina, Novogene, PerkinElmer & More - Yahoo Finance
Cell Free DNA (cfDNA) Testing Market Outlook to 2028 & 2033 - GlobeNewswire Inc.
Finanzdaten der Agilent Technologies Inc-Aktie (A)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):